Xuekun Wu
Carl Neuberg Str. 1
Hannover, NI 30625, Germany
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
3-Dimensional Human iPSC-Derived Cardiac Organoids for Antifibrotic Drug Screening.
Journal: Circulation research
Published: September 03, 2026
Reimagining human-centric drug development with new approach methodologies.
Journal: Science (New York, N.Y.)
Published: April 16, 2026
Cardiac fibrosis: from mechanisms and models to medicines.
Journal: Trends in pharmacological sciences
Published: April 27, 2025
PDK4 drives abdominal aortic aneurysm by promoting smooth muscle cell metabolic reprogramming and NLRP3-mediated pyroptosis.
Journal: Nature communications
Published: March 09, 2025
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.
Journal: Annual review of pharmacology and toxicology
Published: September 16, 2024
Clinical trials in-a-dish for cardiovascular medicine.
Journal: European heart journal
Published: February 26, 2024
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target.
Journal: Cell
Published: December 05, 2023
Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair.
Journal: Nature cardiovascular research
Published: June 28, 2023
Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option.
Journal: European heart journal
Published: March 17, 2023
Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase.
Journal: Science (New York, N.Y.)
Published: June 16, 2022
Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes.
Journal: Circulation
Published: August 10, 2021
Last Updated: 09/26/2026